UiPath, Inc. provides an automation platform offering robotic process automation (RPA) solutions, primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. Its UiPath platform is an integrated enterprise software platform that enables AI agents, robots, people, and models to work together in coordinated workflows. The platform includes UiPath Maestro process orchestration and process intelligence, UiPath agent builder, RPA and API automation, UiPath intelligent extraction and processing, UiPath test cloud for testing and quality assurance, UiPath packaged and prebuilt agentic solutions, and centralized governance capabilities that apply across automations, AI agents, and manual tasks. It serves the financial services, healthcare, manufacturing, retail, and public sectors. The company was founded in 2005 and is headquartered in New York, New York.
UiPath beat Q2 but AI competition fears sank the stock
▲
Sector rally lifted software stocks A broad rally in enterprise software, sparked by strong Salesforce and CrowdStrike results, pushed UiPath up nearly 9% before its own earnings. When investors feel better about the whole software group, beaten-down names like UiPath get bought too.
Explains the pre-earnings price jump and the sector mood behind it.
▲
Q2 results beat and guidance raised UiPath reported $410 million revenue, up 13%, beat estimates, and posted its fourth straight quarter of accounting profit. It raised full-year revenue guidance. Solid numbers and real profits support the stock because they show the business is still growing and making money.
The earnings beat and raised outlook are the core fundamental news of the period.
▼
Stock plunged on competition and weak ARR outlook Despite the beat, shares fell about 17-24% because the ARR guidance barely rose and next-quarter revenue midpoint missed consensus. Investors fear AI rivals are winning automation deals, so they sold first and asked questions later. This is the main reason PATH is down.
This is the dominant driver of the period's price drop and the key counterweight to the good results.
◆
New agentic AI products, but analysts stay cautious UiPath launched coding agents, a delegate AI agent, data fabric and governance tools, plus Linux support. That could win back enterprise trust, but UBS and RBC cut targets to $15, calling it a 'show-me story' until ARR growth actually accelerates.
Shows the company's answer to competition and why analysts still want proof before turning positive.
Q3 2026
▼2▲1
UiPath's AI progress offset by ARR growth worries and OpenAI competition
▲
First GAAP operating profit and Q2 beat UiPath posted its first GAAP operating profit, beat Q2 estimates with $410M revenue (up 13%), and raised full-year guidance, showing its AI pivot is gaining traction.
This is a key positive development that drove investor optimism during the quarter.
▼
OpenAI's competing AI agent product OpenAI's competing AI agent product triggered a 15% drop in UiPath shares, highlighting intensifying competition in the AI automation space.
This competitive threat was a major negative force on the stock during the period.
▼
Weak ARR guidance and soft revenue outlook Weak ARR guidance—barely rising with a soft next-quarter revenue midpoint—sent the stock down 17–24% despite the earnings beat, as investors worried about future growth.
This guidance disappointment was a primary driver of the stock's decline.
◆
Analyst caution and price target cuts Analysts remain cautious, calling PATH a 'show-me story' until ARR growth accelerates, with UBS and RBC cutting targets to $15, reflecting tempered expectations.
Analyst actions influenced sentiment and valuation during the quarter.
News & notes movingPATH
United States
Artificial Intelligence▼2
UBS and RBC Cut UiPath Price Targets to $15 on ARR Guidance Silence
UBS cut its price target on UiPath from $19 to $15 and kept a Neutral rating on September 22, while RBC Capital also lowered its target from $17 to $15 with a Sector Perform rating. UBS noted that UiPath did not provide preliminary fiscal 2028 annual recurring revenue guidance at its investor day, which the firm read as the company being comfortable with Street estimates of roughly 10% ARR growth for the year. RBC described UiPath as a "show-me story" and is looking for evidence of improved results. In Q2 fiscal 2027, revenue rose 13% year-over-year to $410 million, ARR rose 12% to $1.938 billion as of July 31, 2026, and the company generated $37 million in net new ARR. UiPath ended the quarter with approximately 10,350 customers, with customers generating more than $30,000 in ARR up 6% year-over-year, those with at least $100,000 in ARR up 10% to 2,666, and those with $1 million or more in ARR up 21% to 387, a group that accounted for 50% of current-period revenue. Short interest stood at 25.56% of the float as of August 31, while hedge fund holders rose to 48 in the second quarter from 40 in the first.
Artificial Intelligence › Agentic AI & Autonomous Workflows Competition
PATH · Capital · Negative UBS and RBC both cut UiPath price targets to $15, citing no preliminary FY2028 ARR guidance and calling it a 'show-me story'.
UiPath Unveils Agentic AI Platform Upgrades as PATH Shares Lag Market
UiPath announced new and expanded platform capabilities across agentic AI, automation, enterprise data, connectivity, and governance on Wednesday, a move that could give the struggling stock a fresh catalyst. The updates include general availability of UiPath coding agents, a new delegate AI agent for repetitive administrative and testing tasks, an expanded integration service and data fabric linking agents and workflows to enterprise systems and governed business data, and new governance tools such as a runtime checker and model hub to monitor models, agent behavior, access, and compliance. The automation suite is also now available on Linux, giving enterprises with stricter security and data-sovereignty requirements more deployment control. The product news lands as UiPath shares are down 19.16% year to date, compared with a 13.43% gain for the S&P 500, and down nearly 5% over the past week. On the weekly chart the stock is trying to stabilize around $13.20, with RSI near 42.8 below the neutral 50 level and a slightly negative MACD; a move above $13.50 could signal improving momentum, while a break below $13.20 could put recent lows back in focus.
Artificial Intelligence › Agentic AI & Autonomous Workflows ▲Technology
PATH · Technology · Positive UiPath announced new and expanded agentic AI platform capabilities, including coding agents, a delegate AI agent, data fabric, and governance tools.
UiPath Adds Governance, Data and Agent Capabilities Across Its Platform
UiPath announced updated and enhanced capabilities across the UiPath Platform, strengthening its control plane for governance, data, connectivity and deployment. UiPath Coding Agents, announced in May 2026, are now generally available on the platform, letting enterprises build and optimize automations using Coding Agents, Claude Code, Cursor, Codex, Antigravity or other supported agents, while the new UiPath Delegate productivity agent acts on a user's behalf for administrative and role-specific tasks including software testing. UiPath Integration Service adds four capabilities: Database Hub, Relay, Third-Party Credential Store and an MCP Connector, and UiPath Data Fabric now turns distributed enterprise data into governed, reusable context, with Federated Entities providing zero-copy connectivity to external sources such as Salesforce and SAP. New governance controls include Model Hub, Runtime Checker, LLM-as-Judge Guardrail, Compliance Packs and Identity & Access Policies, all under one policy framework applying to agents, robots and people alike. UiPath Automation Suite is now available on Linux with the full UiPath Platform agentic AI stack, giving organizations with strict regulatory, sovereignty or security requirements in-house control over where data runs and how policies are enforced.
Artificial Intelligence › Agentic AI & Autonomous Workflows ▲Technology
Cloud & Digital Infrastructure › Observability & DevOps Technology
Artificial Intelligence › AI Applications & Copilots ▲Technology
PATH · Technology · Positive UiPath announced GA of Coding Agents and new governance, data, integration and Linux deployment capabilities across its platform.
UiPath Unveils Test Cloud Enhancements Toward Autonomous Dark Testing Factory
UiPath announced new and planned enhancements to UiPath Test Cloud that let teams execute tests autonomously, explore applications with AI agents, and automate more of the testing lifecycle. The capabilities are building blocks toward what UiPath calls the dark testing factory, a continuous operating model in which AI agents and automation take on more testing and maintenance work while quality engineering professionals set testing conditions, resolve ambiguity, and remain responsible for risk and release decisions. Gerd Weishaar, SVP of Product, Testing Solutions at UiPath, said AI-generated code is widening the gap between software development and testing, and that Test Cloud lets quality engineering teams hand more routine testing work to AI agents, including creating and maintaining automations. UiPath Test Cloud provides a central platform for managing and orchestrating testing across an application portfolio, and the new capabilities extend that foundation. UiPath, Inc. trades on the NYSE under PATH.
UiPath Earns Zacks Rank #2 as Earnings Estimates Rise
UiPath has been rated Zacks Rank #2 (Buy), with the consensus estimate for the current quarter rising 15.2% over the last 30 days to $0.18 per share, a year-over-year change of +12.5%. For the current fiscal year, the consensus earnings estimate of $0.79 points to a change of +9.7% from the prior year and has moved +19.1% over the past 30 days, while the next fiscal year's estimate of $0.91 indicates a change of +14.1% and has changed +0.4% over the past month. The consensus sales estimate of $442.63 million for the current quarter points to a year-over-year change of +7.7%, with the $1.79 billion and $1.94 billion estimates for the current and next fiscal years indicating changes of +11.1% and +8.1%, respectively. In the last reported quarter, UiPath reported revenues of $410.26 million, a year-over-year change of +13.4%, and EPS of $0.15, matching the year-ago figure, with a revenue surprise of +3.19% against the Zacks Consensus Estimate of $397.59 million and an EPS surprise of 0%. The stock has returned -13.6% over the past month versus the Zacks S&P 500 composite's -1.3% change, while the Zacks Internet - Software industry has gained 7.8% over this period, and UiPath carries a Zacks Value Style Score of C.
Artificial Intelligence › Agentic AI & Autonomous Workflows Demand
PATH · Capital · Positive UiPath earned Zacks Rank #2 (Buy) with consensus earnings estimates rising 15.2% for the current quarter, an analyst valuation upgrade.
UiPath Q2 FY2027 Results Beat Guidance, Outlook Raised, Shares Fall 16.6%
UiPath reported Q2 FY2027 results that beat management's guidance and raised its fiscal 2027 outlook, yet the shares fell 16.6% on September 4, the first trading day after the report, while the S&P 500 slipped 0.4%. ARR, the subscription run-rate UiPath manages by, reached $1.938 billion, up 12%, and the $37 million added in the quarter topped the $31 million added a year earlier, while dollar-based net retention rose to 109%. Revenue was $410 million, up 13%, and non-GAAP operating income reached $89 million, a 22% margin; management raised its fiscal 2027 non-GAAP operating income target to about $445 million from $430 million and lifted the fiscal 2027 revenue guide to about $1.79 billion from a prior guide of about $1.78 billion. Adjusted free cash flow was softer at $31 million against $45 million a year earlier, which management tied mainly to the timing of tax-related payments. AI was part of 18 of the 20 largest deals, customers with $1 million or more of ARR rose 21% to 387, and UiPath ended the quarter with roughly 10,350 customers, though management put no number on the AI business and said agentic pricing is still being tested. The next test is ARR as of October 31, guided to $1.992 billion to $1.997 billion, ahead of the Investor Day on September 22.
UiPath Deploys AI Platform at PLDT, Saving 30,000 Hours Annually
UiPath announced that PLDT, the leading digital services provider in the Philippines, has scaled its service delivery using the UiPath Platform to support rising demand driven by accelerating 5G adoption, expanding broadband usage, and growing satellite connectivity nationwide. PLDT embedded UiPath business orchestration and automation capabilities into its core workflows, deploying three AI solutions to address specific operational bottlenecks. KAI, its instant knowledge retrieval tool, cuts a manual research process of up to five days to contextual responses in one to three seconds, creating approximately 12 FTE-equivalent annual productivity capacity and reducing an estimated 25,000 to 30,000 hours of manual effort annually, a 99% faster response rate. Ellie, an internal AI-powered digital assistant, reduces manual effort by 25 to 35%, saves an estimated 18,000 to 25,000 hours annually, and delivers up to 80% faster customer response times. ERICA, an agentic risk intelligence capability deployed in February 2026, slashes complex evaluations from two to ten days to five minutes to one day, driving a 97% to 99% reduction in manual effort. Karl Crowther, UiPath Area Vice President for the Middle East, Africa and South Asia, said customer expectations are rising alongside 5G, broadband and digital services growth, and Gilbert Gaw, PLDT and Smart First Vice President and Head of IT and Transformation Office, said the partnership brings greater intelligence into PLDT's operations.
Artificial Intelligence › Agentic AI & Autonomous Workflows ▲Demand
Cloud & Digital Infrastructure › Horizontal SaaS Technology
Artificial Intelligence › AI Applications & Copilots ▲Demand
PATH · Demand · Positive PLDT scaled its service delivery using the UiPath Platform, deploying three AI solutions — a concrete customer adoption/deployment win for UiPath.
UiPath sank 4% to $13.49 despite Citi's fresh Buy rating and $23 target, as a below-expectations Q3 revenue guide of $442.5M spooked investors. Peers Pegasystems and C3.ai dropped 3% and 1% respectively, as the market demands proven AI-era monetization over strategic pitches. UiPath's September 22 investor day and Fusion conference are the next catalysts, with bulls pointing to $1.4B cash and zero debt as the floor.
UiPath Survey: Orchestration Key to Scaling Agentic AI
UiPath released a global survey of 600 C-Suite and IT practitioners at large companies, revealing that while many enterprises are stuck in agentic AI pilot purgatory, those prioritizing orchestration scale faster and achieve meaningful ROI. Only 31% of respondents reported AI fully embedded in their business, with 35% adopting it on a limited basis and 11% stuck in pilot mode. Key challenges include data quality (38%), integration (37%), and governance (33%). Among enterprises with fully embedded orchestration, 89% said their agentic implementations met or exceeded ROI expectations. The survey, conducted between May 25 and June 8, 2026, also found that 36% expect agents to play a significant role in workflows within the next 12 months, with 52% focusing on hybrid workflows, yet only 29% have orchestration fully embedded.
Artificial Intelligence › Agentic AI & Autonomous Workflows Demand
PATH · Demand · Positive Survey highlights orchestration as key to scaling agentic AI, positioning UiPath's platform as critical for enterprise adoption and ROI.
Synthesized Launches UiPath Integration for Automated Test Data
Synthesized, the AI-native test data automation platform, has announced an integration with UiPath Test Cloud that automates test data provisioning within the UiPath testing workflow. The integration enables teams to invoke configured Synthesized data workflows as part of their UiPath testing process, ensuring compliant, production-realistic, and connected test data is available on demand. This addresses common blockers such as unavailable or consumed data, compliance issues with production data, and inconsistent data across connected systems. By making test data preparation a native step inside UiPath Test Cloud, the integration reduces manual setup, improves test coverage, and accelerates delivery. The integration is available now, and Synthesized is an official sponsor of UiPath FUSION 2026, taking place September 22–25 in Las Vegas.
UiPath, a major business automation software company, saw its shares plunge sharply on the 4th, falling as much as 19% intraday to $14.77, before closing down 16.63% at $15.19. The company reported its fiscal Q2 results for the period ending January 2027 after the previous day's close, with revenue up 13% year-over-year to $410.3 million and adjusted EPS of $0.15, in line with market expectations. Despite raising its full-year forecast, selling pressure dominated due to concerns over intensifying competition. Revenue breakdown: subscription revenue from its own AI services rose 11.6% to $266 million, while licensing revenue increased 10.4% to $124 million. For Q3, the company expects revenue of $440 million to $445 million and adjusted operating income of approximately $100 million. For the full year, it raised its outlook to revenue of $1.789 billion to $1.794 billion and adjusted operating income of approximately $445 million. Additionally, the company announced a management reshuffle, with Hitesh Ramani promoted to CFO and Brad Brubaker appointed as CLAO.
UiPath Shares Fall 16% on Mixed Q2 Results and Cautious Guidance
UiPath shares fell 16.4% in afternoon trading after the automation software company reported second-quarter CY2026 results that missed high expectations for AI-linked companies. Revenue rose 13.4% year over year to $410.3 million, beating Wall Street estimates of $397.9 million, while adjusted earnings per share of $0.15 met consensus. However, billings came in at $375.5 million, slightly missing expectations, and management cited longer customer decision-making cycles as enterprises evaluate AI-driven automation. CEO Daniel Dines noted that 18 of the top 20 deals in the quarter included AI, but new CFO Hitesh Ramani said the company is taking a prudent approach to guidance due to macroeconomic variability and shifts in customer adoption. UiPath is down 4.8% year to date and trades 21.6% below its 52-week high.
UiPath shares tumbled nearly 17% on Friday after its fiscal second-quarter results failed to convince investors that a full growth reacceleration was underway. The stock closed at $15.19, down $3.03, on volume of roughly 104 million shares, about 1.57 times its one-month average. The company reported revenue of $410 million, ARR of $1.93 billion, and net-new ARR of $37 million, with non-GAAP EPS of $0.15 in line with estimates and revenue beating consensus by $12.41 million. Despite the beat, concerns centered on modest net-new ARR, slowing growth relative to AI-focused peers, and competitive risks in agentic automation. UiPath also announced executive leadership changes, including Hitesh Ramani's promotion to CFO and Ashim Gupta's transition to focus solely on the COO role.
UiPath Promotes Hitesh Ramani to CFO, Appoints Yazdi Bagli to Board
UiPath, Inc. announced a series of executive leadership changes, including the promotion of Hitesh Ramani to Chief Financial Officer and the appointment of Yazdi Bagli to its Board of Directors. Ramani, who joined UiPath in 2021 as Chief Accounting Officer and became Deputy CFO in 2024, will lead the global financial and accounting organization. Ashim Gupta will continue as Chief Operating Officer, focusing exclusively on day-to-day operations, while Brad Brubaker has been named Chief Legal & Administrative Officer, adding oversight of the People Organization to his current role as Chief Legal Officer and General Counsel. Bagli, currently on leave from his role as Executive Vice President at Kaiser Permanente, brings experience from Walmart and Procter & Gamble. CEO Daniel Dines said the changes reflect the company's focus on execution and position it for its next phase of growth.
PATH · · Neutral UiPath promotes Hitesh Ramani to CFO and appoints Yazdi Bagli to its board; leadership changes with no clear financial or operational driver.
Enterprise Software Stocks Rally as Salesforce CEO Declares End of SaaSpocalypse
Enterprise software and cybersecurity stocks rallied sharply on Thursday, driven by strong earnings and a shift in the AI narrative. The iShares Expanded Tech-Software Sector ETF (IGV) surged over 6%, on track for its largest single-day gain since April 9, 2025, when it jumped 11.7%. The rally began after Salesforce and CrowdStrike reported better-than-expected second-quarter results, with Salesforce CEO Marc Benioff declaring, "This nonsense of this SaaSpocalypse, I think it's time for it to stop." ServiceNow surged 9%, Workday rose nearly 4%, and Adobe and Autodesk each climbed 6%. Cybersecurity names led the gains, with CrowdStrike up 18%, Okta rocketing over 25%, and SailPoint surging nearly 14%. Palantir increased 4% as its Maven Smart System is on track to generate at least $1 billion in annual recurring revenue, while UiPath climbed nearly 9% ahead of its earnings report.
Banco Azteca Scales to 8,800 Orchestrated Processes with UiPath Maestro
UiPath announced that Banco Azteca, one of Mexico's largest financial institutions, has transformed its automation program using UiPath Maestro to orchestrate complex, end-to-end business processes across more than 8,800 enterprise processes and more than 300 automations. Since launching its automation journey in 2020 and establishing an internal AI and RPA Center of Excellence, the bank has built one of Latin America's most mature automation programs, led by over 20 developers, business analysts, and data scientists under the executive sponsorship of Manuel Delgado Forey, Chief Operating Officer and Head of Customer Service. The orchestrated workflows, which coordinate people, AI agents, systems, and third-party partners, have scaled to the equivalent of over 3,300 full-time employees, improving visibility, governance, and scalability. A flagship example is Elektra's post-sales operation for elektra.mx, which now processes cancellation, delivery, and order-related requests with reduced manual effort and significantly accelerated resolution times. Looking ahead, Banco Azteca plans to extend this model into anti-money laundering initiatives and intelligent ATM monitoring.
Cloud & Digital Infrastructure › Horizontal SaaS ▲Demand
Artificial Intelligence › Agentic AI & Autonomous Workflows ▲Demand
PATH · Demand · Positive Banco Azteca, a major customer, scales to 8,800 orchestrated processes using UiPath Maestro, showcasing product adoption and expansion.
Banco Azteca · Technology · Positive Banco Azteca's automation program with UiPath Maestro improves operational efficiency and plans to extend to AML and ATM monitoring.
Leveraged ETFs on Microsoft, AXT, UiPath, and Amazon Surge After Earnings
Leveraged single-stock ETFs tied to Microsoft, AXT, UiPath, and Amazon posted sharp gains last week following strong earnings reports. The Direxion Daily MSFT Bull 2X ETF rose 38.9% as Microsoft shares jumped 19% after better-than-expected fiscal fourth-quarter 2026 results driven by Azure growth and AI demand. The Tradr 2X Long AXTI Daily ETF gained 35.4% as AXT shares surged 24.7% on a blowout second-quarter 2026 report with record indium phosphide revenues. The Tradr 2X Long PATH Daily ETF advanced 32.6% as UiPath shares climbed 14.2% on strong enterprise demand for AI-driven automation. The GraniteShares 2x Long AMZN Daily ETF added 31.0% as Amazon shares rose 15.3% after an AWS-fueled earnings beat that sent the stock up 10% immediately, with AWS revenue jumping 37% and its AI business and chips each generating over $25 billion in annualized revenue.
Tetragon Financial Group Reports Negative 2.5% NAV Return for First Half of 2026
Tetragon Financial Group Ltd reported a negative net asset value per share total return of 2.5% for the first half of 2026. Fully diluted NAV per share fell to $46.00 at June 30, 2026, down from $41.88 at the end of 2025. The company declared a dividend of $0.12 per share for the second quarter, unchanged from the first quarter, representing an annualized yield of approximately 3.6%. Aggregate investment performance was a net loss of $131.4 million, driven by a $138.9 million loss in private equity and venture capital, mainly from a decline in Ripple's share price from $150 to $109, and a $69.2 million loss in other equities due to mark-to-market losses in UiPath. These were partially offset by a $120.2 million gain in Tetragon Partners, driven by BGO and Equitix investments. The company's net cash position was negative $135.8 million at the end of June, with $185 million drawn on its revolving credit facility.
U.S. Robotics Stocks Gain as Physical AI, Surgical Competition, and Defense Autonomy Accelerate
The American robotics industry has entered a decisive acceleration phase in 2026, with June and July emerging as a landmark period across physical AI, surgical systems, defense autonomy, and elder care. In June, BMW Group announced plans to deploy Figure AI's third-generation Figure 03 humanoid at its Spartanburg plant, while NEURA Robotics closed a Series C worth up to $1.4 billion, and humanoid startups have raised $8.6 billion in 2026, 1.8 times the full-year 2025 total. On July 22, the FDA granted de novo authorization to Johnson & Johnson's Ottava system for ten general surgery procedures, breaking a long era of single-platform dominance, and Medtronic unveiled its AI-native Touch Surgery Aide platform. Defense robotics drew fresh capital with Mach Industries raising $300 million and Shifters securing $10.2 million, while the global elder care assistive robot market is projected at $3.9 billion in 2026, reaching $9.8 billion by 2033. Synopsys raised its fiscal 2026 revenue guidance to $9.665 billion at midpoint, AMD unveiled its Ryzen AI Embedded X100 Series for robotics, Manhattan Associates reaffirmed full-year guidance of $1.15 billion in revenues, and UiPath targets fiscal 2027 ARR of approximately $2.06 billion.
Robotics & Physical AI › Surgical & Medical Robotics ▲Regulation
Robotics & Physical AI › Robotics AI & Embodiment Software ▲Technology
Robotics & Physical AI › Civil Drones & UAV ▲Capital
Aging Population › Medical Devices for the Aging Body ▲Technology
SNPS · Capital · Positive Synopsys raised its fiscal 2026 revenue guidance to $9.665 billion at midpoint.
Figure AI · Demand · Positive BMW Group announced plans to deploy Figure AI's third-generation Figure 03 humanoid at its Spartanburg plant.
Mach Industries · Capital · Positive Mach Industries raised $300 million in defense robotics funding.
NEURA Robotics · Capital · Positive NEURA Robotics closed a Series C worth up to $1.4 billion.
BMW.XETRA · Demand · Positive BMW Group announced plans to deploy Figure AI's humanoid robots at its Spartanburg plant, indicating demand for automation.
JNJ · Regulation · Positive FDA granted de novo authorization to J&J's Ottava system for ten general surgery procedures.
Marvell Technology posts steady quarterly revenue growth while UiPath fluctuates
Marvell Technology and UiPath both reported year-over-year revenue increases in their latest quarters, but their quarterly trends diverged. Marvell Technology, which joined the S&P 500 on June 22, 2026, grew revenue sequentially from $2.2 billion in the quarter ended January 2026 to $2.4 billion in the quarter ended May 2026, and it forecasts about $2.7 billion next quarter. UiPath saw revenue rise 17% year over year to $418.4 million in the quarter ended April 2026, though that was down from $481.1 million in the prior quarter, and it guided for $395 million to $400 million next quarter. Over the past 12 months through July 24, Marvell’s stock surged over 150% while UiPath’s fell more than 10%.
UiPath Stock Falls 15% After OpenAI Launch, But Sell-Off May Be Overdone
UiPath shares dropped nearly 15% from their recent peak by midday Thursday, triggered by OpenAI's launch of a new offering called OpenAI Presence. The solution helps organizations deploy AI agents for customer service, sales, HR, and IT support, but it focuses on probabilistic tasks, while UiPath's software bots handle deterministic, rules-based work like data entry and payroll where accuracy is critical. UiPath's own agentic AI platform, Maestro, can route tasks to either AI agents or cheaper software bots and is model-agnostic, reducing reliance on any single AI vendor. With the stock trading at a forward P/E of about 13.5 and a price-to-sales ratio just above 3, the pullback appears overdone, and UiPath could play an important role in enterprise AI agent orchestration.
UiPath Gains on Retail AI Partnership with The Very Group
UiPath closed at $12.15, up 1.00%, following a retail artificial intelligence partnership with UK online retailer The Very Group. The enterprise automation and robotic software provider will supply agentic AI pricing solutions under the deal. Trading volume reached 90.6 million shares, about 86% above its three-month average of 48.7 million shares. The stock has fallen 81% since its 2021 IPO and remains down over 26% year-to-date despite the day's gains.
UiPath vs. ServiceNow: Which Agentic AI Stock Is the Better Buy?
ServiceNow and UiPath are both positioned to benefit from the enterprise agentic AI market, which Grand View Research forecasts will grow at a 46.2% compound annual rate through 2030. ServiceNow has higher annual recurring revenue growth, with subscription revenue up 22% year-over-year in its latest quarter, compared to UiPath's 12% subscription growth and 17% overall revenue increase. ServiceNow also has 630 customers spending more than $5 million annually, while UiPath has 374 customers spending over $1 million. However, UiPath recently achieved GAAP profitability in a fiscal first quarter for the first time, and its net profit margin of just above 5% has more room to expand toward ServiceNow's double-digit margins, potentially improving its valuation. Both companies trade at similar price-to-earnings ratios, but UiPath may offer better value for long-term investors focused on margin expansion.
Artificial Intelligence › Agentic AI & Autonomous Workflows ▲Competition
NOW · Demand · Positive ServiceNow has higher subscription revenue growth (22% YoY) and more large customers spending over $5M annually, indicating strong demand for its agentic AI platform.
PATH · Capital · Positive UiPath achieved GAAP profitability for the first time and has room for margin expansion, potentially improving its valuation.
UiPath Could Be 10% Undervalued After The Very Group Contract
UiPath stock is in focus after the company signed a three-year contract to build an AI-driven pricing platform for UK online retailer The Very Group. The stock last closed at $11.95, and a popular narrative fair value estimate of $13.31 suggests it could be about 10.2% undervalued. Recent momentum includes a 30-day share price return of 10.75%, though the five-year total shareholder return has declined roughly 81%. The company is emphasizing its agentic automation roadmap and go-to-market changes to deepen customer relationships and boost annual recurring revenue growth, while facing pressure points such as softer net new ARR, foreign exchange headwinds, and execution risks tied to a shift toward more SaaS-style contracts.
UiPath Reports First GAAP Operating Profit and AI Retail Win
UiPath reported its first-ever quarterly GAAP operating profit and announced a three-year agreement to build an AI-driven pricing platform for UK online retailer The Very Group. The company also highlighted that its AI agentic products are progressing from pilot to production, while maintaining a share repurchase program with about US$414 million still available. The Very Group deal underscores how UiPath's automation and AI tools are being applied to complex, margin-sensitive retail decisions, moving beyond small pilots into scaled production. The first GAAP operating profit supports the investment thesis of a durable, subscription-heavy software franchise with improving profitability, though softer near-term ARR guidance keeps execution risk in focus.
UiPath Stock Appears Undervalued by 40.6% on Cash Flow Basis After AI Contract Win
UiPath shares are trading near US$11.95, and a Discounted Cash Flow analysis suggests the stock may be undervalued by about 40.6% relative to an estimated intrinsic value of US$20.12 per share. The company generated approximately US$368.4 million in free cash flow over the last twelve months, and the valuation assumes continued cash flow growth, supported in part by a recent AI-driven automation contract with The Very Group. On an earnings basis, UiPath trades at about 18.9 times earnings, well below the broader Software industry average of 28.8 times and a peer group average near 40.4 times, while a tailored fair P/E ratio factoring in its growth profile and margins is estimated at roughly 24.8 times. Despite these valuation signals, the stock has declined around 81.0% over the past five years, and ongoing concerns about execution quality and competitive pressure in automation and AI remain key risks that could explain the market's cautious pricing.
Zebra Technologies and UiPath both trade at 15 times forward earnings as automation demand rises
Zebra Technologies and UiPath are both trading at around 15 times forward earnings, with Zebra's stock up more than 11% this year. Zebra reported first-quarter sales of $1.49 billion, up 14.3% year over year, and lifted its full-year 2026 outlook to sales growth of 10% to 14% and non-GAAP EPS between $18.30 and $18.70. UiPath posted revenue of $418.4 million in its fiscal 2027 first quarter, up 17.3% year over year, and achieved its third consecutive quarter of GAAP profitability with EPS of $0.04. Both companies are benefiting from strong industrial automation trends, with a RobCo survey finding that 95% of U.S. industrial firms plan to introduce new automation over the next three years.
IonQ, SoundHound AI, and UiPath touted as better moonshot bets than SpaceX
The Motley Fool highlights IonQ, SoundHound AI, and UiPath as three speculative growth stocks that may be better moonshot investments than SpaceX. IonQ leads in quantum computing accuracy with trapped-ion qubits achieving 99.99% two-qubit gate fidelity, though it remains far from fault-tolerant operation, and it is acquiring SkyWater for a dedicated foundry. SoundHound AI, whose shares have fallen about 30% this year, is pursuing the customer service market through its pending acquisition of LivePerson, which would add a large customer base to its voice AI platform following its earlier Amelia deal. UiPath trades at a forward price-to-sales ratio of 3.5 and a forward price-to-earnings ratio of 15, and it aims to become an agentic AI orchestration leader by leveraging its robotic process automation foundation and Maestro platform, with revenue up 17% last quarter.
Artificial Intelligence › Agentic AI & Autonomous Workflows Competition
Artificial Intelligence › AI Applications & Copilots Competition
IONQ · Technology · Positive IonQ's quantum computing accuracy milestone (99.99% fidelity) and acquisition of SkyWater for dedicated foundry are highlighted as positive developments.
PATH · Technology · Positive UiPath is positioned as an agentic AI orchestration leader with its Maestro platform and 17% revenue growth.
SOUN · Capital · Positive SoundHound AI's pending acquisition of LivePerson and earlier Amelia deal are highlighted as growth catalysts.
LPSN · Capital · Positive SoundHound AI's pending acquisition of LivePerson is expected to add a large customer base, boosting its voice AI platform.
SKYT · Capital · Positive SkyWater is being acquired by IonQ, which is a positive event for the company.
StockStory Highlights Vertiv as Cash-Rich Buy, Flags UiPath and Surgery Partners as Risky
StockStory identifies Vertiv as a cash-producing stock worth buying, while labeling UiPath and Surgery Partners as risky investments. Vertiv, formerly part of Emerson Electric, boasts a trailing 12-month free cash flow margin of 21.2%, average organic revenue growth of 23.7% over two years, and a free cash flow margin that increased by 22.4 percentage points over five years. In contrast, UiPath's annual revenue growth of 11.2% over two years and estimated sales growth of 8.2% for the next 12 months raise concerns, while Surgery Partners faces estimated sales growth of just 3.2% and a high net-debt-to-EBITDA ratio of 7×. Vertiv trades at $301.70 per share, UiPath at $11.70, and Surgery Partners at $16.89.
UiPath Gains as Agentic Automation Strategy Faces Earnings Test
UiPath closed at $11.69, up 1.21%, as investors focus on its agentic automation strategy ahead of the next earnings report. The company is moving beyond traditional robotic process automation to position itself as an orchestration layer for complex enterprise workflows, with the launch of Maestro Case supporting this shift. The upcoming earnings update is expected to provide clarity on whether the strategy is driving durable growth and higher enterprise demand. Meanwhile, the S&P 500 was unchanged at 7,483.24, and the Nasdaq Composite fell 0.80% to 25,832.
UiPath Launches Maestro Case to Tackle Complex Enterprise Workflows
UiPath has introduced Maestro Case, a new capability aimed at helping enterprises manage complex, non-linear workflows that involve people, systems, and AI. The tool treats each case as an evolving workflow, carrying data and context across stages while blending automation with human oversight, targeting fragmented processes often handled through emails and spreadsheets. The move positions UiPath more directly against ServiceNow and Pegasystems in workflow orchestration and case management, with its AI-led approach potentially offering differentiation. UiPath stock has fallen 39% year to date, and it trades at a forward price-to-earnings ratio of 11.91, below the industry average of 24.48, while the Zacks Consensus Estimate for fiscal 2027 earnings has risen over the past 30 days.
Automation software stocks fall 19.1% on average after Q1 earnings despite revenue beats
Automation software stocks tracked by this publication fell an average of 19.1% since their latest earnings results, even as the group's revenues beat analysts' consensus estimates by 1.5% and next-quarter revenue guidance was in line. UiPath reported revenues of $418.4 million, up 17.3% year on year and exceeding expectations by 5.2%, but its full-year revenue guidance only slightly topped estimates and it significantly missed billings estimates, sending its stock down 14%. SoundHound AI posted the fastest revenue growth among peers at 51.7% year on year to $44.2 million, beating estimates by 3.4%, yet its stock dropped 35.6%. Pegasystems recorded the weakest performance with revenues of $430 million, down 9.6% year on year and missing estimates by 7.3%, leading to a 25.8% stock decline. ServiceNow's revenues rose 22.1% year on year to $3.77 billion, beating estimates by 0.6%, but its stock fell 12.8%. Microsoft's revenues grew 18.3% year on year to $82.89 billion, topping estimates by 1.7%, and its stock declined 16.3%.
UiPath vs. Nu Holdings: Which Disruptive Growth Stock is a Buy?
UiPath appears to be a buy right now, while Nu Holdings faces near-term uncertainty from Brazil's high interest rates. UiPath is evolving into an enterprise AI orchestration platform, with AI product adoption driving higher customer spending and deeper enterprise relationships. The Zacks Consensus Estimate for UiPath's second-quarter fiscal 2027 earnings is 15 cents per share, flat year-over-year, on revenues of $397.6 million, up 9.9%. For full fiscal 2027, earnings are projected to increase 11.1%, followed by 12.7% growth in fiscal 2028, with revenues rising 10.4% and 8.2% respectively. Nu Holdings trades at roughly 12.63 times forward earnings, with expected revenue growth of 39% and EPS growth of 34% this year, and generates a 13.4% return on invested capital and a 30.9% return on equity. However, Brazil's central bank aggressively raised benchmark interest rates from 10.5% in June 2024 to 14.25% in June this year, then only slightly reduced them to 14.5%, heightening fears of an economic slowdown and consumer financial stress that could pressure Nu's loan book. UiPath carries a Zacks Rank #2 (Buy) and Nu carries a Zacks Rank #3 (Hold).
NU · Monetary · Negative Brazil's high interest rates (14.5%) heighten fears of economic slowdown and consumer financial stress, pressuring Nu's loan book.
PATH · Demand · Positive UiPath's AI product adoption is driving higher customer spending and deeper enterprise relationships, with revenue growth expected.
PATH · Technology · Positive UiPath is evolving into an enterprise AI orchestration platform with AI product adoption driving higher customer spending.
USDBRL.FOREX · Monetary · Negative Brazil's central bank raised rates aggressively, strengthening BRL relative to USD.
StockStory identifies Adobe, UiPath, and United Parks & Resorts as value stocks with structural challenges that investors should steer clear of. Adobe, trading at $195.58 per share with a forward price-to-sales ratio of 2.9x, showed sluggish demand with projected sales growth of 9.9% and flat operating margins. UiPath, priced at $10.32 and a 3x forward price-to-sales ratio, faces weak billings growth of 9.3% and estimated sales growth of 8.2%, signaling a slowdown. United Parks & Resorts, at $46.89 and a 10.6x forward price-to-earnings ratio, struggles with declining visitors, a low free cash flow margin of 12.1%, and waning returns on capital.
UiPath Stock Draws Heavy Investor Attention Amid Strong Earnings Estimate Revisions
UiPath has become one of the most searched stocks on Zacks.com, prompting a review of factors that could influence its near-term performance. Over the past month, shares of the enterprise automation software developer have returned negative 7%, while the Zacks Internet - Software industry lost 4.7% and the S&P 500 gained 0.1%. The Zacks Consensus Estimate for current-quarter earnings stands at $0.15 per share, unchanged from a year ago, but has surged 74.2% over the last 30 days. For the current fiscal year, the consensus estimate of $0.79 per share reflects a 9.7% increase from the prior year and has risen 18.4% in the past month, while the next fiscal year's estimate of $0.90 per share indicates 14.3% growth and has been revised 3.8% higher. These positive revisions have earned UiPath a Zacks Rank #2, or Buy, suggesting it may outperform the broader market in the near term.
PATH · Capital · Positive Strong upward revisions to earnings estimates and a Zacks Rank #2 (Buy) indicate positive analyst sentiment and potential outperformance.
UiPath Falls as Agentic Automation Push Faces ARR Growth Test
UiPath shares declined 1.07% to close at $10.15 despite the launch of Maestro Case, an AI-native tool for coordinating agents, robots, and people in complex enterprise workflows. Trading volume reached 51.8 million shares, about 47% above the three-month average of 33.6 million. The broader market also fell, with the S&P 500 down 0.37% and the Nasdaq Composite dropping 1.32%. Peer Pegasystems closed 2.36% lower at $29.38, highlighting continued pressure on automation names. Investors remain focused on whether UiPath's agentic automation push will translate into stronger annual recurring revenue growth, retention, and customer expansion in upcoming earnings.